BIOMEDE
2026Adding biomarker-matched erlotinib, everolimus or dasatinib to radiotherapy did NOT improve overall survival in DIPG (median OS ~10–12 months across arms, no different from historical controls), but...
In patients with 5 to 20 brain metastases, does stereotactic radiation targeting individual tumors reduce symptom burden and interference with daily function compared with hippocampal-avoidance whole brain radiation?
Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical Trial
Bottom Line: In patients with 5 to 20 brain metastases, stereotactic radiation improved patient-reported symptoms and interference with daily functioning compared with hippocampal-avoidance whole brain radiation, supporting stereotactic radiation as the preferred approach.
Adding biomarker-matched erlotinib, everolimus or dasatinib to radiotherapy did NOT improve overall survival in DIPG (median OS ~10–12 months across arms, no different from historical controls), but...
A single intratumoral injection of CAN-3110 produced deep and persistent T cell infiltration in recurrent GBM by locally expanding pre-existing tumor-infiltrating T cell clones; shorter GZMB+ CD8 T ce...
Monthly early palliative care did not significantly improve the primary FACT-Br Trial Outcome Index at 6 months, but produced consistent benefits in emotional well-being, palliative-care symptom burde...
Adding low-dose WBRT (23.4 Gy) to R-MPV-A chemoimmunotherapy substantially improved 2-year PFS (78.7% vs 54%, HR 0.47, P=0.007) and complete response rates without producing measurable excess neurocog...
Does intraoperative radiotherapy delivered to the resection cavity provide effective local control and acceptable safety in patients with newly diagnosed brain metastases?
In patients with 5 to 20 brain metastases, does stereotactic radiation targeting individual tumors reduce symptom burden and interference with daily function compared with hippocampal-avoidance whole brain radiation?
Does stereotactic radiation provide better patient-reported outcomes than hippocampal-avoidance whole brain radiation in patients with 5-20 brain metastases?
Can a CDK4/6 inhibitor shrink or stabilize progressive meningiomas harboring NF2 or CDK pathway mutations?
Does oncolytic herpes virus treatment reprogram the glioblastoma immune microenvironment to enable T cell-mediated tumor killing?
Oncolytic Virus for Recurrent Glioblastoma — Spatial Omics Analysis